Evidence map›Paper›PMID 36902454›Full record

ArticleInternational journal of molecular sciences2023

Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency.

Rosa Cifuentes, José Padilla, María Eugenia de la Morena-Barrio, Belén de la Morena-Barrio, Carlos Bravo-Pérez, Pedro Garrido-Rodríguez, María Llamas, Antonia Miñano, Vicente Vicente, María Luisa Lozano and 1 more

Full text read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Long-Read Sequencing Identified aHuman mutation · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rosa CifuentesServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.
José PadillaServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.
María Eugenia de la Morena-BarrioServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.ORCID 0000-0001-7426-4947
Belén de la Morena-BarrioServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.
Carlos Bravo-PérezServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.ORCID 0000-0001-9794-7847
Pedro Garrido-RodríguezServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.ORCID 0000-0003-3447-248X
María LlamasServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.
Antonia MiñanoServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.
Vicente VicenteServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.ORCID 0000-0002-4278-3264
María Luisa LozanoServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.ORCID 0000-0003-3148-7037
Javier CorralServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.

Funding

Centre for Biomedical Network Research on Rare Diseases Postdoctoral contractCentre for Biomedical Network Research on Rare Diseases Predoctoral contractInstituto de Salud Carlos III CM20/00094Instituto de Salud Carlos III PFIS Rosa CifuentesInstituto de Salud Carlos III PI21/00174Instituto de Salud Carlos III PMP21/00052Ministerio de Ciencia e Innovación España RYC2021-031000-I
6 · The paper itself

Abstract

Multiplex ligation-dependent probe amplification (MLPA) identifies genetic structural variants in

Indexed as

ThrombophiliaAntithrombinsExonsHumansIntronsMultiplex Polymerase Chain ReactionNucleotidesAntithrombinsNucleotidesantithrombin deficiencygenetic variantsmultiplex ligation-dependent probe amplificationstructural variants

Identifiers

PMID36902454
PMCPMC10002544

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read7
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.